サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409506

低ホスファターゼ症治療の世界市場レポート 2024年

Hypophosphatasia Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
低ホスファターゼ症治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

低ホスファターゼ症治療市場規模は近年着実に成長しています。2023年の26億8,000万米ドルから2024年には28億1,000万米ドルへと、CAGR5.0％で拡大します。過去の期間に見られた成長は、限られた治療選択肢、この疾患に対する認知度の向上、臨床試験の世界化、ヘルスケアインフラの発展、この分野への投資と資金調達など、いくつかの要因によるものです。

低ホスファターゼ症治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR5.3％で34億5,000万米ドルに成長します。予測期間中の成長が見込まれる背景には、新たな治療法の登場、患者数の増加、精密医療の動向、政府の取り組み、疾患に対する認知度の向上などがあります。予測期間に予想される世界の動向には、治療アプローチの進歩、研究開発イニシアティブへの注力の高まり、市場の拡大と世界展開、業界内の提携やパートナーシップ、規制状況の進化への配慮などが含まれます。

予測される調査市場の成長は、生物医学研究活動への投資の増加によってもたらされます。これらの投資は、科学的研究技術を通じて生物医学の理論を検証し、人間の健康に関する独自の側面に関する知識を拡大することを含みます。生物医学研究投資は、稀な遺伝性骨疾患である低ホスファターゼ症の効率的で改善された治療のための新薬や治療法の開発において重要な役割を果たしています。メディケア＆メディケイド・サービスセンターが2023年9月に報告したように、米国の国民医療費は2021年に2.7％の伸びを示し、4兆3,000億米ドルに達しました。2022年から2031年までの国民医療費の予測平均成長率は5.4％で、GDPの平均成長率4.6％を上回る。この軌跡により、GDPに占める医療費の割合は2021年の18.3%から2031年には19.6%に増加すると予想されます。このように、生物医学研究投資の増加は、低ホスファターゼ症治療市場成長の重要な促進要因となっています。

低ホスファターゼ症治療市場の成長が期待される背景には、老人人口の増加もあります。65歳以上の高齢者人口は、低ホスファターゼ症関連ヘルスケアサービスの需要に寄与しています。これには早期診断と長期管理が含まれ、高齢化する人口層におけるこの病態の理解と治療の進歩を促進しています。2022年10月の世界保健機関（WHO）の報告によると、2030年までに世界の6人に1人が60歳以上になり、2050年までに60歳以上の人口は21億人になると予想されています。したがって、老人人口の増加は低ホスファターゼ症治療市場を推進する重要な要因となっています。

2023年の低ホスファターゼ症治療市場では北米が最大地域でした。低ホスファターゼ症治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 低ホスファターゼ症治療市場の特徴

第3章 低ホスファターゼ症治療市場の動向と戦略

第4章 低ホスファターゼ症治療市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の低ホスファターゼ症治療市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 低ホスファターゼ症治療市場セグメンテーション

  • 世界の低ホスファターゼ症治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 歯限局型低ホスファターゼ症
  • 偽性低ホスファターゼ症
  • その他のタイプ
  • 世界の低ホスファターゼ症治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 酵素補充療法
  • 薬剤
  • 手術
  • その他の治療
  • 世界の低ホスファターゼ症治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 注射
  • 世界の低ホスファターゼ症治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • オンライン薬局
  • 小売薬局
  • 世界の低ホスファターゼ症治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 在宅ケア
  • 専門クリニック
  • その他のエンドユーザー

第7章 低ホスファターゼ症治療市場の地域および国分析

  • 世界の低ホスファターゼ症治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の低ホスファターゼ症治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の低ホスファターゼ症治療市場

第9章 中国の低ホスファターゼ症治療市場

第10章 インドの低ホスファターゼ症治療市場

第11章 日本の低ホスファターゼ症治療市場

第12章 オーストラリアの低ホスファターゼ症治療市場

第13章 インドネシアの低ホスファターゼ症治療市場

第14章 韓国の低ホスファターゼ症治療市場

第15章 西欧の低ホスファターゼ症治療市場

第16章 英国の低ホスファターゼ症治療市場

第17章 ドイツの低ホスファターゼ症治療市場

第18章 フランスの低ホスファターゼ症治療市場

第19章 イタリアの低ホスファターゼ症治療市場

第20章 スペインの低ホスファターゼ症治療市場

第21章 東欧の低ホスファターゼ症治療市場

第22章 ロシアの低ホスファターゼ症治療市場

第23章 北米の低ホスファターゼ症治療市場

第24章 米国の低ホスファターゼ症治療市場

第25章 カナダの低ホスファターゼ症治療市場

第26章 南米低ホスファターゼ症治療市場

第27章 ブラジルの低ホスファターゼ症治療市場

第28章 中東の低ホスファターゼ症治療市場

第29章 アフリカの低ホスファターゼ症治療市場

第30章 低ホスファターゼ症治療市場の競合情勢と企業プロファイル

  • 低ホスファターゼ症治療市場の競合情勢
  • 低ホスファターゼ症治療市場の企業プロファイル
    • Kirin Holdings Company Limited
    • Vericel Corporation
    • Mereo Biopharma Group plc
    • Novartis AG
    • AM-Pharma BV

第31章 世界の低ホスファターゼ症治療市場の競合ベンチマーキング

第32章 世界の低ホスファターゼ症治療市場競争力ダッシュボード

第33章 低ホスファターゼ症治療市場における主要な合併と買収

第34章 低ホスファターゼ症治療市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11044

“Hypophosphatasia Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hypophosphatasia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hypophosphatasia treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hypophosphatasia treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Odontohypophosphatasia; Pseudohypophosphatasia; Other Types
  • 2) By Treatment: Enzyme Replacement Therapy; Medication; Surgery; Other Treatments
  • 3) By Route of Administration: Oral; Injectable
  • 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
  • 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
  • Companies Mentioned: Kirin Holdings Company Limited; Vericel Corporation; Mereo Biopharma Group plc; Novartis AG; AM-Pharma B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hypophosphatasia treatment involves addressing an inherited disorder that affects the development of bones and teeth, also known as Rathbun disease. This disorder disrupts the mineralization process, impacting the deposition of calcium and phosphorus in developing bones and teeth.

The major types of hypophosphatasia disorders include odontohypophosphatasia, pseudohypophosphatasia, and others, and they can be treated through various methods such as enzyme replacement therapies, medications, and surgeries. Odontohypophosphatasia is a specific subtype of hypophosphatasia (HPP) characterized by lower activity of unfractionated serum alkaline phosphatase, premature exfoliation of primary and permanent teeth, and severe dental caries. Treatment methods may be administered orally or through injections. Distribution channels for these treatments include hospital pharmacies, online pharmacies, and retail pharmacies, catering to end users such as hospitals, homecare, specialty clinics, among others.

The hypophosphatasia treatment market research report is one of a series of new reports from The Business Research Company that provides hypophosphatasia treatment market statistics, including hypophosphatasia treatment industry global market size, regional shares, competitors with a hypophosphatasia treatment market share, detailed hypophosphatasia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hypophosphatasia treatment industry. This hypophosphatasia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hypophosphatasia treatment market size has grown steadily in recent years. It will grow from $2.68 billion in 2023 to $2.81 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth observed in the historical period can be attributed to several factors, including limited treatment options, increased awareness of the condition, the globalization of clinical trials, development in healthcare infrastructure, and investments and funding in the field.

The hypophosphatasia treatment market size is expected to see strong growth in the next few years. It will grow to $3.45 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be attributed to emerging therapies, a growing patient pool, trends in precision medicine, government initiatives, and increased awareness of the disease. Major trends expected in the forecast period include advancements in therapeutic approaches, increased focus on research and development initiatives, market expansion and global reach, collaborations and partnerships within the industry, and considerations of the evolving regulatory landscape.

The anticipated growth of the hypophosphatasia treatment market is driven by the increasing investments in biomedical research activities. These investments involve verifying biomedical science theories through scientific research techniques and expanding knowledge about unique aspects of human health. Biomedical research investments play a crucial role in developing new drugs and therapies for the efficient and improved treatment of hypophosphatasia, a rare inherited bone disorder. As reported by the Centers for Medicare & Medicaid Services in September 2023, national health expenditure in the United States experienced a 2.7% growth in 2021, reaching $4.3 trillion. The average projected growth in national health expenditure from 2022 to 2031 is 5.4%, surpassing the average GDP growth of 4.6%. This trajectory is expected to result in an increased health spending share of GDP from 18.3% in 2021 to 19.6% in 2031. Thus, the rise in biomedical research investments is a significant driver for the growth of the hypophosphatasia treatment market.

The anticipated growth of the hypophosphatasia treatment market is also attributed to the increasing geriatric population. The geriatric population, comprising individuals aged 65 years and above, contributes to the demand for hypophosphatasia-related healthcare services. This includes early diagnosis and long-term management, driving advancements in understanding and treating this condition within the aging demographic. According to the World Health Organization (WHO) report in October 2022, one in six people worldwide is expected to be 60 or older by 2030, and by 2050, there will be 2.1 billion people aged 60 or older. Therefore, the growing geriatric population is a significant factor propelling the hypophosphatasia treatment market.

Strategic partnerships have emerged as a noteworthy trend in the hypophosphatasia market, with major companies focusing on collaborations to strengthen their market position. For example, in November 2021, Genomenon Inc. collaborated with AstraZeneca to enhance access to crucial data for detecting and managing rare disorders, including hypophosphatasia. The goal is to provide genetic testing facilities with the necessary information to identify rare diseases. Additionally, in June 2021, Aruvant Sciences partnered with Aldevron Madison LLC to aid in developing potentially curative medicines for conditions such as sickle cell anemia and hypophosphatasia.

Major companies operating in the hypophosphatasia treatment market are adopting a strategic partnership approach to enhance supply chain resilience. In August 2023, AdventHealth partnered with Medline Industries LP to optimize the supply chain, leveraging the capabilities of a national health system and an industry partner. This collaboration enhances inventory control and distribution strategy, promoting improved patient outcomes and cost optimization. This structured approach strengthens the supply chain's resilience and establishes a framework to support future growth.

In July 2021, AstraZeneca acquired Alexion Pharmaceutical Inc. for an undisclosed amount, marking the company's entry into the development of medications for uncommon diseases, including hypophosphatasia. Alexion Pharmaceutical Inc., a U.S.-based manufacturer of medicine for hypophosphatasia treatment, became part of AstraZeneca through this acquisition.

Major companies operating in the hypophosphatasia treatment market report are Kirin Holdings Company Limited, Vericel Corporation, Mereo Biopharma Group plc, Novartis AG, AM-Pharma B.V., Bayer AG, Pfizer Inc., Ultragenyx Pharmaceutical Inc., BioMarin Pharmaceutical Inc., Prior Company Ltd., Enobia Pharma Corporation, AstraZeneca plc, Rallybio Corporation, AbCellera Biologics Inc., Inozyme Pharma Inc., Aruvant Sciences Pte. Ltd., Alexion Pharmaceuticals Inc., Asfotase Alfa, Merck Co. & KGaA, Kyowa Kirin Co.Ltd., Shire plc, Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Roche Holding AG, Johnson & Johnson Services Inc., AbbVie Inc., Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Celgene Corporation, Gilead Sciences Inc., Incyte Corporation, Ipsen S.A., Jazz Pharmaceuticals plc, Mallinckrodt Pharmaceuticals, Regeneron Pharmaceuticals Inc

North America was the largest region in the hypophosphatasia treatment market in 2023. The regions covered in the hypophosphatasia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hypophosphatasia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hypophosphatasia treatment market consists of revenues earned by entities by providing hypophosphatasia treatment services, such as regular dental care, physical and occupational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypophosphatasia treatment market also includes sales of nonsteroidal anti-inflammatory drugs (NSAIDs) and vitamin B6 tablets or capsules which are used in providing hypophosphatasia treatment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Hypophosphatasia Treatment Market Characteristics

3. Hypophosphatasia Treatment Market Trends And Strategies

4. Hypophosphatasia Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Hypophosphatasia Treatment Market Size and Growth

  • 5.1. Global Hypophosphatasia Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hypophosphatasia Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hypophosphatasia Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hypophosphatasia Treatment Market Segmentation

  • 6.1. Global Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Odontohypophosphatasia
  • Pseudohypophosphatasia
  • Other Types
  • 6.2. Global Hypophosphatasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzyme Replacement Therapy
  • Medication
  • Surgery
  • Other Treatments
  • 6.3. Global Hypophosphatasia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectable
  • 6.4. Global Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • 6.5. Global Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End Users

7. Hypophosphatasia Treatment Market Regional And Country Analysis

  • 7.1. Global Hypophosphatasia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hypophosphatasia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hypophosphatasia Treatment Market

  • 8.1. Asia-Pacific Hypophosphatasia Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hypophosphatasia Treatment Market

  • 9.1. China Hypophosphatasia Treatment Market Overview
  • 9.2. China Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hypophosphatasia Treatment Market

  • 10.1. India Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hypophosphatasia Treatment Market

  • 11.1. Japan Hypophosphatasia Treatment Market Overview
  • 11.2. Japan Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hypophosphatasia Treatment Market

  • 12.1. Australia Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hypophosphatasia Treatment Market

  • 13.1. Indonesia Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hypophosphatasia Treatment Market

  • 14.1. South Korea Hypophosphatasia Treatment Market Overview
  • 14.2. South Korea Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hypophosphatasia Treatment Market

  • 15.1. Western Europe Hypophosphatasia Treatment Market Overview
  • 15.2. Western Europe Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hypophosphatasia Treatment Market

  • 16.1. UK Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hypophosphatasia Treatment Market

  • 17.1. Germany Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hypophosphatasia Treatment Market

  • 18.1. France Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hypophosphatasia Treatment Market

  • 19.1. Italy Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hypophosphatasia Treatment Market

  • 20.1. Spain Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hypophosphatasia Treatment Market

  • 21.1. Eastern Europe Hypophosphatasia Treatment Market Overview
  • 21.2. Eastern Europe Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hypophosphatasia Treatment Market

  • 22.1. Russia Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hypophosphatasia Treatment Market

  • 23.1. North America Hypophosphatasia Treatment Market Overview
  • 23.2. North America Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hypophosphatasia Treatment Market

  • 24.1. USA Hypophosphatasia Treatment Market Overview
  • 24.2. USA Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hypophosphatasia Treatment Market

  • 25.1. Canada Hypophosphatasia Treatment Market Overview
  • 25.2. Canada Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hypophosphatasia Treatment Market

  • 26.1. South America Hypophosphatasia Treatment Market Overview
  • 26.2. South America Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hypophosphatasia Treatment Market

  • 27.1. Brazil Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hypophosphatasia Treatment Market

  • 28.1. Middle East Hypophosphatasia Treatment Market Overview
  • 28.2. Middle East Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hypophosphatasia Treatment Market

  • 29.1. Africa Hypophosphatasia Treatment Market Overview
  • 29.2. Africa Hypophosphatasia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hypophosphatasia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hypophosphatasia Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hypophosphatasia Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Hypophosphatasia Treatment Market Competitive Landscape
  • 30.2. Hypophosphatasia Treatment Market Company Profiles
    • 30.2.1. Kirin Holdings Company Limited
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Vericel Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Mereo Biopharma Group plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AM-Pharma B.V.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Hypophosphatasia Treatment Market Competitive Benchmarking

32. Global Hypophosphatasia Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hypophosphatasia Treatment Market

34. Hypophosphatasia Treatment Market Future Outlook and Potential Analysis

  • 34.1 Hypophosphatasia Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Hypophosphatasia Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Hypophosphatasia Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer